Drugs / flufenamic acid
last change Oct 2020 re-read 2 minutes ago

flufenamic acid

Small molecule

Developed for
influenza
Investigated by
The University of Hong Kong

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03238612 Jan 2018 → Jul 2020 influenza The University of Hong Kong Unknown No outcome recorded

Evidence & citations 14 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as flufenamic acid “2-day course of triple combination of clarithromycin 500mg, flufenamic acid 200mg and oseltamivir 75mg twice daily followed by oseltamivir 75mg twice daily for 3 days” NCT03238612
Known as Acide flufenamique ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Known as Acido flufenamico ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Known as Arlef ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Known as CI 440 ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Known as CN-27,554 ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Known as FFA “flufenamic acid (FFA) have been shown to inhibit seasonal influenza virus infection” NCT03238612
Known as Flufenamate ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Known as INF-1837 ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Known as Meralen ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Known as NSC-219007 ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Known as NSC-82699 ChEMBL registry synonym — accepted as the source's own label CHEMBL23588
Action Inhibit “flufenamic acid (FFA) have been shown to inhibit seasonal influenza virus infection” NCT03238612
Modality Small molecule CHEMBL23588